Skip to main content

Techniques of Delivering Hyperthermic Intraperitoneal Chemotherapy

  • Chapter
Intraperitoneal Cancer Therapy

Abstract

Hyperthermic intraperitoneal chemotherapy (HIPEC) was first delivered to a human in 1979 by Dr. John Spratt at the University of Louisville when he treated a male patient with pseudomyxoma peritonei (1). In collaboration with other researchers, he developed a delivery system using a “closed” technique, with both the fascia and skin closed.

Since that time, there has been increasing interest around the world in the delivery of HIPEC. The most widely used methods have involved perioperative perfusion of chemotherapy in heated perfusate performed at the time of open laparotomy (see the following sections), but delivery of HIPEC has also been reported with laparoscopic placement of inflow and outflow tubing (2) and regional (3) and whole-body hyperthermia (4).

Hyperthermic intraperitoneal chemotherapy requires an organized team within the operating room who all understand their roles. The anesthesiologist manages the cooling of the patient’s core temperature before the hyperthermic perfusion and monitors the patient’s vital parameters, particularly the core temperature, during the perfusion. The perfusionist, often recruited from cardiac surgery because of experience with the techniques of cardiopulmonary bypass, operates the heat exchange pump and equipment for the perfusion. Although it is everyone’s responsibility, the scrub technicians and circulating nurses are charged with the specific duty of ensuring proper adherence to operating room protocol for the use of hazardous agents.

The two main techniques for hyperthermic IP perfusion are “open,” where the incision is open during the HIPEC, and “closed” where the abdominal skin and/or fascia are closed. Both basic methods have been extensively utilized, with many individual variations. In this chapter, the most widely used open technique, the “Coliseum,” and the closed technique will be described and discusse

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Spratt JS, Adcock RA, Muskovin M, et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980;40(2):256–260.

    PubMed  CAS  Google Scholar 

  2. Chang E, Alexander HR, Libutti SK, et al. Laparoscopic continuous hyperthermic peritoneal perfusion. J Am Coll Surg 2001;193(2):225–229.

    Article  PubMed  CAS  Google Scholar 

  3. Leopold KA, Oleson JR, Clarke-Pearson D, et al. Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinoma. Int J Radiat Oncol Biol Phys 1993;27(5):1245–1251.

    PubMed  CAS  Google Scholar 

  4. Robins HI, Cohen JD, Schmitt CL, et al. Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients. J Clin Oncol 1993;11:1787–1794.

    PubMed  CAS  Google Scholar 

  5. Sugarbaker PH. Management of Peritoneal Surface Malignancy. Preface. Surg Oncol Clin N Am 2003;12(3):xxi–xxiv.

    Article  PubMed  Google Scholar 

  6. Sugarbaker PH, Yu W, Yonemura Y. Gastrectomy, peritonectomy and perioperative intraperitoneal chemotherapy: The evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 2003;21:233–248.

    Article  PubMed  Google Scholar 

  7. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999;6(8):790–796.

    Article  PubMed  CAS  Google Scholar 

  8. Fujimura T, Yonemura Y, Fushida S, et al. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65(1):65–71.

    Article  PubMed  CAS  Google Scholar 

  9. Yamagushi A, Tsukioka Y, Fushida S, et al. Intraperitoneal hyperthermic treatment for peritoneal dissemination of colorectal cancers. Dis Colon Rectum 1992;35(10):964–968.

    Article  Google Scholar 

  10. Yonemura Y, Ninomiya I, Kaji M, et al. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg 1995;19(3):450–454.

    Article  PubMed  CAS  Google Scholar 

  11. Yoshida Y, Sasaki H, Kurokawa T, et al. Efficacy of intraperitoneal continuous hyperthermic chemotherapy as consolidation therapy in patients with advanced epithelial ovarian cancer: a long-term follow-up. Oncol Rep 2005;13(1):121–125.

    PubMed  CAS  Google Scholar 

  12. Ryu KS, Kim JH, Ko HS, et al. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Gynecol Oncol 2004;94(2):325–332.

    Article  PubMed  CAS  Google Scholar 

  13. Elias D, Antoun S, Goharin A, et al. Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int J Surg Invest 2000;1(5):431–439.

    CAS  Google Scholar 

  14. Loggie BW, Sterchi JM, Rogers AT, et al. Intraperitoneal hyperthermic chemotherapy for advanced gastrointestinal and ovarian cancers. Reg Cancer Treat 1994;2:78–81.

    Google Scholar 

  15. Bartlett DL, Buell JF, Libutti SK, et al. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis [erratum appears in Cancer 1998;83(10):2241]. Cancer 1998;83(6):1251–1261.

    Article  PubMed  CAS  Google Scholar 

  16. Fujimoto S, Takahashi M, Mutou T, et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997;79(5):884–891.

    Article  PubMed  CAS  Google Scholar 

  17. Steller MA, Egorin MJ, Trimble EL, et al. A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer [erratum appears in Cancer Chemother Pharmacol 1999;44(1):90]. Cancer Chemother Pharmacol 1999;43(2):106–114.

    Article  PubMed  CAS  Google Scholar 

  18. Deraco M, Rossi CR, Pennacchioli E, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: A phase II clinical study. Tumori 2001;87:120–126.

    PubMed  CAS  Google Scholar 

  19. de Bree E, Romanos J, Michalakis J, et al. Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin. Anticancer Res 2003;23(3C):3019–3027.

    PubMed  Google Scholar 

  20. Ahmad SA, Sussman JJ, Kim J, et al. Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2003;10:574.

    Google Scholar 

  21. Sayag-Beaujard AC, Francois Y, Glehen O, et al. Treatment of peritoneal carcinomatosis in patients with digestive cancers with combination intraperitoneal hyperthermia and mitomycin C. Bulletin du Cancer 2004;91(5):113–132.

    Google Scholar 

  22. Zanon C, Clara R, Chiappino I, et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer. World J Surg 2004;28(10):1040–1045.

    Article  PubMed  Google Scholar 

  23. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999;6(8):790–796.

    Article  PubMed  CAS  Google Scholar 

  24. Shimizu T, Maeta M, Koga S. Influence of local hyperthermia on the healing of small intestinal anastomoses in the rat. Brit J Surg 1991;78(1):57–59.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Esquivel, J., Sugarbaker, P.H., Helm, C.W. (2007). Techniques of Delivering Hyperthermic Intraperitoneal Chemotherapy. In: Helm, C.W., Edwards, R.P. (eds) Intraperitoneal Cancer Therapy. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-59745-195-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-195-6_11

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-878-2

  • Online ISBN: 978-1-59745-195-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics